In order to investigate the involvement of cGAS in COPA syndrome pathology, CRISPR/Cas9 gene editing was employed to delete COPA in a monoclonal cGAS knockout (cGAS−/−) THP-1 cell line44. This evidence concerns the gene CGAS and autoimmune interstitial lung disease-arthritis syndrome.